US Broker Ratings

Alvotech (ALVO) Stock Analysis: Exploring a Potential 328% Upside in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based biotech firm specializing in biosimilar medicines, is capturing investor attention with its remarkable potential upside of 328.15%. As a player in the Healthcare sector, specifically within..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: An Investor’s Guide to 22.97% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its focus on rare disorders and a promising development pipeline. Based..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 62.3% Upside Potential in Biotech Innovation

Investors looking at the healthcare sector, particularly in the biotechnology industry, may find Zai Lab Limited (NASDAQ: ZLAB) a compelling opportunity. With a current market capitalization of $2.32 billion, this..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 22% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a biopharmaceutical company focused on neuroscience, is currently capturing the attention of investors with its potential for substantial upside. Based in Burnaby, Canada, Xenon is..

Warby Parker Inc. (WRBY) Investor Outlook: Analyzing a 22.63% Potential Upside in the Healthcare Sector

Warby Parker Inc. (NYSE: WRBY), a trailblazer in the eyewear industry with a strong presence in both retail and e-commerce across the United States and Canada, is drawing significant attention..

PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a prominent player in the healthcare sector, particularly within the medical devices industry, is drawing investor attention with its innovative surgical robotics technology and a..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Growth

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is attracting significant investor attention as it navigates the competitive biotechnology landscape, focusing on neurological and rare disease treatments. This article examines the company’s current..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 10.83% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (ICUI), a prominent player in the Healthcare sector specializing in Medical Instruments & Supplies, offers promising opportunities for investors seeking growth in the medical devices space. Headquartered..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking a 10.78% Potential Upside for Investors

For investors seeking exposure in the healthcare sector, Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity. With a market capitalization of $3.55 billion, this Boston-based medical technology firm stands out..

Perrigo Company plc (PRGO): Exploring a 55% Upside Potential Amidst High Dividend Yields

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, stands as a prominent player in the drug manufacturers industry, focusing on specialty and generic medications. Headquartered in Dublin,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a $10 Billion Valuation and Strategic Growth in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing investor interest with its strategic focus on genetic medicines targeting diseases with high unmet medical needs...

Guardant Health, Inc. (GH) Stock Analysis: Unpacking a 48% Revenue Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) has emerged as a formidable player in the diagnostics and research segment of the healthcare industry. With a market capitalization of $20.67 billion, this precision..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 33.81% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has been a topic of interest among investors due to its extensive range of over-the-counter (OTC) health..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth with a 15.59% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic products, presents an intriguing opportunity for investors..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a Potential 11.54% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare industry, primarily focuses on medical instruments and supplies, particularly within the eye health sector. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 23.48% ROE in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector known for its diagnostic and therapeutic innovations, presents an intriguing prospect for investors keen on the drug manufacturing..

TG Therapeutics, Inc. (TGTX): Investor Outlook on a Biotech Powerhouse with 6.39% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a significant player in the biotechnology sector, boasting a market capitalization of $8.4 billion. Renowned for its innovative approach in the healthcare industry,..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 22.65% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has been capturing investor attention with its promising pipeline and robust market performance. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential Amidst a 12.36% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical entity within the specialty and generic drug manufacturing industry. Headquartered in Hyderabad,..

Waystar Holding Corp. (WAY) Stock Analysis: Strong Buy Ratings and a Promising 50% Upside Potential

For investors seeking opportunities in the healthcare sector, Waystar Holding Corp. (WAY) presents an intriguing proposition. With its focus on developing innovative cloud-based software solutions for healthcare payments, Waystar stands..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds